Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share (Details)

v3.8.0.1
Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share (Details) - shares
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Anti-dilutive securities 882,000 988,000
Options to Purchase Common Stock [Member]    
Anti-dilutive securities 426,000 779,000
Warrants to Purchase Common Stock [Member]    
Anti-dilutive securities 209,000 209,000
Notes Payable Convertible to Common Stock [Member]    
Anti-dilutive securities 247,000